Search for: "Barr Laboratories" Results 101 - 120 of 373
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2018, 5:45 pm by Bill Marler
Identification of this parasite in stool requires special laboratory tests that are not routinely done. [read post]
6 Jul 2018, 2:01 pm by Josh Fensterbush
Identification of this parasite in stool requires special laboratory tests that are not routinely done. [read post]
9 Aug 2018, 8:13 pm by Drew Falkenstein
Identification of this parasite in stool requires special laboratory tests that are not routinely done. [read post]
16 Aug 2019, 9:28 pm by Bill Marler
Identification of this parasite in stool requires special laboratory tests that are not routinely done. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & Anor (IPKat) (The SPC… [read post]
3 Mar 2010, 7:55 am by Tom Lamb
Bayer is also taking over Barr´s defense in certain cases according to the parties´ supply and licensing agreement.... [read post]
18 May 2015, 12:40 pm
LabCorp is one of the country’s largest providers of outpatient laboratory services, and it’s planning to allow anyone to drop in without having to visit a doctor first. [read post]
26 Apr 2011, 11:15 pm
Barr Pharmaceutical manufactured Claravis, which contains the same active agent as Accutane (isotretinoin). [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs)   Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
24 Oct 2008, 7:49 pm
In this case, Barr Laboratories sought permission to market a generic version of Cipro before the expiration of Bayer's patent on Cipro's active ingredient. [read post]
26 May 2009, 3:22 pm
READ MORE ON CAMPYLOBACTER AND GULLAIN BARRE SYNDROMEIII. [read post]
9 Jun 2016, 9:35 pm by Bruce Clark
Signs and Symptoms: –  Watery or Bloody Diarrhea – Nausea –  Abdominal pain – Fever –  Myalgia Complication of campylobacteriosis include reactive arthritis, irritable bowel syndrome, and Guillain- Barre syndrome. [read post]
25 Oct 2011, 9:28 am by Jenna Greene
The FTC also lost a case in the 11th Circuit challenging a pay for delay deal between Schering-Plough Corp., Upsher-Smith Laboratories and American Home Products Corp. involving the high blood pressure medication K-Dur 20. [read post]
3 Mar 2010, 12:49 pm by Jason Krebs
  Bayer, makers of the popular, but problematic birth control drug Yaz and Yasmin wrote that there were, about 1,100 lawsuits pending in the United States served on Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Bayer’s oral contraceptive products Yasmin®, yaz® and / or Ocella, a generic version of Yasmin® distributed by Barr Laboratories, Inc. in the u.s. market. [read post]
19 Sep 2017, 11:24 am by Bill Marler
Further laboratory testing, completed on Friday, confirmed the presence of Campylobacter jejuni in the raw milk sample. [read post]